baber/WOPTO huggingface dataset:
Patent BR-PI0900018-B1 (BR)
Title: Controlador de motor de combustão interna
Inventor: FUMINOBU HONGOH
IPC: F02D41/10
Filed: 2009-01-12
Abstract: controlador de motor de combustão interna. é descrito um controlador de um motor de combustão interna operável por um combustível que contém álcool que inclui: uma unidade de detecção de concentração de álcool operável para detectar a concentração de álcool do combustível que contém álcool; um controlador de realimentação operável para realizar controle de realimentação para fazer a proporção ar - combustível de exaustão do motor de combustão interna ficar igual a uma proporção ar - combustível visada de acordo com uma região operacional; e uma unidade de ajuste da região operacional operável para ajustar uma região operacional estequiométrica na qual a proporção ar - combustível visada é estequiométrica de uma maneira ampliada quando a concentração de álcool, detectada pela unidade de detecção de concentração de álcool, for mais alta do que uma concentração.
Patent BR-PI0920129-B1 (BR)
Title: Fixador de alinhamento interno para alinhar dois tubos a serem soldados um ao outro no mar, uso do fixador de alinhamento interno e método para soldar dois tubos
Inventor: ANDREA PROVESI
IPC: B23K37/053
Filed: 2009-10-21
Abstract: método e aparelho para medir o alinhamento de dois tubos a serem soldados um ao outro a presente invenção refere-se a um dispositivo de aperto de alinhamento interno (20), para alinhar dois tubos a serem soldados um ao outro, que inclui um sistema de medição de hi-lo, que compreende, por exemplo, uma fonte de laser (24) e um sistema de câmera (22), montado no dispositivo de aperto de alinhamento interno (20) e disposto para fazer uma medição de hi-lo (d), indicadora do grau de alinhamento dos tubos (10a,10b). a medição pode ser feita quando dois tubos estão apertados um no outro por meio do dispositivo de aperto de alinhamento interno (20). os tubos podem depois ser soldados um ao outro, enquanto os tubos permanecem apertados um ao outro na mesma posição, e enquanto o sistema de medição de hi-lo permanece dentro dos tubos.
Patent BR-PI0920355-B1 (BR)
Title: composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
Inventor: ANTONIO GUGLIETTA
IPC: A61K9/06
Filed: 2009-10-16
Abstract: composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina. a presente invenção refere-se a composições farmacêuticas tópicas estáveis semissólidas contendo entre 0,2 e 5% de um composto des-fluoroquinolona e um carreador adequado para fabricar um unguento ou um creme.
Patent BR-PI1009680-B1 (BR)
Title: Recipiente de misturas de poliamida-polibutadieno com reatividade a oxigênio
Inventor: JEFFREY D BLACK
IPC: C08K5/42
Filed: 2010-06-11
Abstract: recipiente de misturas de poliamida-polibutadieno com reatividade a oxigênio o presente invento descreve o uso de misturas de poliamida-polidieno em recipiente para melhorar a reatividade ao oxigênio na presença de compatibilizantes iônicos de poliéster.
Patent BR-PI1012537-B1 (BR)
Title: Lâmina de cobertura como uma lâmina de alumínio perfurável para uma embalagem blister e embalagem blister
Inventor: ERWIN PASBRIG
IPC: B32B27/20
Filed: 2010-03-09
Abstract: lâmina de cobertura como uma lâ- mina de alumínio perfurável para uma embalagem blister e embalagem blister. a presente invenção refere-se a uma lâmina de cobertura como uma lâmina de alumínio perfurável para uma embalagem blister para embalar produtos sensíveis à umidade, tendo uma lâmina de alumínio agindo como uma camada de barreira contra a penetração de vapor de água e de gases e uma camada de vedação para vedar uma parte da base do blister. uma camada de material plástico contendo agente de secagem de adsorção de umidade é disposta ao lado da lâmina de alumínio fornecida com a camada de vedação.
Patent EA-000964-B1 (EA)
Title: Method for treating or preventing osteoporosis
Inventor: YATES ASHLEY JOHN
IPC: A61K31/675
Filed: 1996-06-03
Abstract: 1. A method of treating or preventing osteoporosis associated with immunosuppressive therapy comprising: administering an effective amount of an active agent, wherein an alendronate or pharamaceutically acceptable salt thereof is used as an active agent to a patient undergoing immunosuppressive therapy. 2. A method according to claim 1 wherein the patient is receiving immunosuppressive therapy in association with an organ transplant. 3. A method according to claim 1, wherein alendronate is in the form of monosodium salt trihydrate. 4. A method according to claim 3, wherein alendronate is administered in a prophylactically effective amount. 5. A method according to claim 4, wherein alendronate is administered orally. 6. A method according to claim 4 wherein alendronate is administered in a dose of from 2.5 to 50 mg per day. 7. A method according to claim 6 wherein alendronate is administered in a dose of 5 mg, 10 mg, or 20 mg per day.
Patent EA-000506-B1 (EA)
Title: Process for purifying alkoxylated fats
Inventor: DRALLE-VOSS GABRIELE
IPC: A61K47/44
Filed: 1996-09-20
Abstract: 1. A process for purifying alkoxylated fats by treatment with a solid substsnce, wherein a mixture of aluminum oxide and a silicate is employed as solid substance. 2. A process as claimed in Claim 1, wherein the treatment is carried out at 15-180 degree C. 3. A process as claimed in Claim 1, wherein an alkali metal or/and alkaline earth metal silicate is used as silicate. 4. A process as claimed in Claim 1, wherein the treatment comprises mixing and stirring the alkoxylated fats with the aluminum oxide and the silicate, and subsequently filtering off the solid substance. 5. A process as claimed in Claim 4, wherein from 0.5 to 15% by weight of the solid substance, based on the complete mixture, are employed. 6. A process as claimed in Claim 4, wherein additionally 0.2% by weight of a filtration aid is added in the treatment. 7. A process as claimed in Claim 1, wherein an acid is added before or after the treatment.
Patent EA-001271-B1 (EA)
Title: Process for breaking explosives in liquid medium
Inventor: SHUTOV VIKTOR PETROVICH
IPC: C06B21/00
Filed: 1998-12-29
Abstract: 1. A process for crushing explosives in liquid medium, comprising feeding material to be crushed in a liquid stream into a crushing chamber with a decreasing gap from the input to the output between working surfaces of a breaker crusher and cyclic action of at least one working surface on the material to be crushed, characterized in that the liquid stream containing the explosives in the form of pieces of different shape and size is fed into the crushing chamber of a jawbreaker having elastic side walls, the explosive material is being crushed gradually on the way to the output of the crushing chamber with a smoothly decreasing gap in a passage between jaws and the cyclic action without displacement in the direction of a movable jaw, the pressure of said jaw exceeds the compression strength of the explosive material to be crushed, the frequency of the cyclic action is set proportionally to the stream discharge via the crushing chamber and the width of the output of the breaker. 2. An installation for breaking explosive materials comprising a crushing chamber, formed by crushing jaws and side walls made of sheet elastic material, characterized in that said side walls are fixed to the side jaw surfaces by rigid limit members mounted with a preset clearance between each other at maximum approaching said crushing jaws. 3. The installation of claim 2, characterized in that said side walls of the chamber are made of thin elastic material.
Patent EA-005852-B1 (EA)
Title: PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
Inventor: BLUMENKOPF TODD ANDREW
IPC: A61K31/505
Filed: 1999-06-14
Abstract: A compound of formula (I) wherein R<1>, R<2> and R<3> are as defined in the description, and are inhibitors of the enzyme protein tyrosine kinases such as Janus Kinase (3) and as such are useful therapy as immunosuppressive agents for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia and other autoimmune diseases.
Patent EA-006940-B1 (EA)
Title: Use of opgl and analogs thereof for opgl down-regulating in an animal
Inventor: HALKIER TORBEN
IPC: C07K/
Filed: 1999-09-13
Abstract: The invention provides a novel method for down-regulating the biological activity of osteoprotegerin ligand (OPGL, TRANCE) thereby rendering possible the treatment/amelioration of diseases characterized by excessive loss of bone mass, e.g. osteoporosis. Down-regulation is effected by inducing an immune response against OPGL in an individual in need thereof. Immune responses can be raised by classical immunization with immunogenic variants of OPGL or by nucleic acid immunization where the nucleic acids encode the OPGL variant. The invention also pertains to compositions, polypeptides and nucleic acids useful in the invention, as well as to vectors and transformed host cells useful in the preparation thereof.
Patent EA-002920-B1 (EA)
Title: Pharmaceutical composition of tizoxanide and nitazoxanide
Inventor: ROSSIGNOL JEAN-FRANCOIS
IPC: A61P31/04
Filed: 1998-05-06
Abstract: 1. A pharmaceutical composition containing as active agent at least one compound selected from the group consisting of: compound of formula (I)   and compound of formula (II)   and pharmaceutically acceptable acid in an amount, improving stability thereof. 2. The composition of Claim 1, wherein said pharmaceutically acceptable acid is selected from the group consisting of citric acid, glutamic acid, succinic acid, ethanesulfonic acid, acetic acid, tartric acid, ascorbic acid, methanesulfonic acid, fumaric acid, adipic acid, malic acid and mixtures thereof. 3. The composition of Claim 2, characterized in that it is solid dosage form wherein the active particles are granulated in the presence of a granulating agent to form granulated active solid particles. 4. The composition of Claim 2, characterized in that it is solid particles suspension of at least one of compounds of formula I and formula II in liquid. 5. The composition of Claim 4, wherein the liquid is water. 6. The composition of Claim 4, wherein the pH of said suspension is between 2 and 6. 7. The composition of Claim 4, wherein the pH of said suspension is between 3 and 5. 8. The composition of Claim 2, which is a paste, said paste comprising solid particles of at least one compounds of formula I and formula II, wetting agent and a thickener.
Patent EA-005107-B1 (EA)
Title: Well treatment process
Inventor: KOTLAR HANS KRISTIAN
IPC: C09K8/54
Filed: 2001-11-19
Abstract: 1. A method for the treatment of a hydrocarbon well which method comprises administering down said well polymeric particles having covalently bound to a polymeric component thereof a well treatment chemical or a precursor thereof, said particles containing covalent bonds scissile in an aqueous environment to release or expose said chemical or precursor. 2. A method as claimed in claim 1 wherein said polymer particles are administered before hydrocarbon production from said well is begun. 3. A method as claimed in either of claims 1 and 2 wherein said polymer particles are placed in a filter in the bore-hole of said well and in the formation surrounding said bore-hole. 4. A method as claimed in any one of claims 1 to 3 wherein said polymer particles are particles as claimed in any one of claims 6 to 9. 5. Polymeric particles having covalently bound to a polymeric component thereof a well treatment chemical or a precursor thereof, said particles containing covalent bonds scissile in an aqueous environment to release or expose said chemical or precursor. 6. Particles as claimed in claim 5 impregnated with an agent capable of promoting revision of said scissile covalent bonds. 7. Particles as claimed in claim 6 wherein said agent is selected from acids, enzymes, bases and metal complexes. 8. Particles as claimed in any one of claims 1 to 7 wherein said scissile covalent bonds are selected from amide, ester, disulphide, diester and peroxide bonds. 9. Particles as claimed in any one of claims 5 to 8 containing a well treatment chemical or precursor or generator thereof selected from scale inhibitors, corrosion inhibitors, wax inhibitors, hydrate inhibitors, asphaltene inhibitors, foamers, biocides, surfactants, oxygen scavengers and bacteria. 10. A hydrocarbon well treatment composition comprising a carrier liquid containing having covalently bound to a polymeric component thereof a well treatment chemical or a precursor thereof, said particles containing covalent bonds scissile in an aqueous environment to release or expose said chemical or precursor. 11. A composition as claimed in claim 10 comprising polymer particles as claimed in any one of claims 6 to 9. 12. A tubular filter for down-hole placement containing having covalently bound to a polymeric component thereof a well treatment chemical or a precursor thereof, said particles containing covalent bonds scissile in an aqueous environment to release or expose said chemical or precursor. 13. A filter as claimed in claim 12 containing polymer particles as claimed in any one of claims 6 to 9. 14. The use for the manufacture of hydrocarbon well treatment compositions of polymeric particles having covalently bound to a polymeric component thereof a well treatment chemical or a precursor thereof, said particles containing covalent bonds scissile in an aqueous environment to release or expose said chemical or precursor. 15. Use as claimed in claim 14 of polymer particles as claimed in any one of claims 6 to 9.
Patent EA-007612-B1 (EA)
Title: Structure-based drug design methods for identifying d-ala-d-ala ligase inhibitors as antibacterial drugs
Inventor: NAVIA MANUEL A
IPC: C12N9/00
Filed: 2002-06-28
Abstract: The invention is based on the discovery that certain small molecules can bind to the ATP binding site of D-Ala-D-Ala ligase, even in the absence of the enzyme's substrate, and can cause a conformational change in the enzyme structure similar to that which occurs upon binding of ATP and substrate to the enzyme. Without wishing to be bound by any theory, it is believed that such a conformational change is required for either activation or inhibition of the enzyme. The information obtained from this discovery has enabled identification of key interactions in the active site of the enzyme, as well as the design and optimization of inhibitors.
Patent EA-007922-B1 (EA)
Title: Chain growth reaction process
Inventor: BRITOVSEK GEORGE JOHAN PETER
IPC: C07C1/32
Filed: 2002-07-05
Abstract: A process is disclosed for the preparation of zinc alkyl chain growth products via a catalysed chain growth reaction of an alpha-olefin on a zinc alkyl, wherein the chain growth catalyst system employs a group 3-10 transition metal, or a group 3 main group metal, or a lanthanide or actinide complex, and optionally a suitable activator. The products can be further converted into alpha-olefins by olefin displacement of the grown alkyls as alpha-olefins from the zinc alkyl chain growth product, or into primary alcohols, by oxidation of the resulting zinc alkyl chain growth product to form alkoxide compounds, followed by hydrolysis of the alkoxides.
Patent EA-010017-B1 (EA)
Title: Substituted arylthiourea derivatives useful as inhibitors of viral replication
Inventor: PHADKE AVINASH
IPC: A61K31/44
Filed: 2004-07-08
Abstract: Substituted arylthiourea compounds of Formula I, and the pharmaceutically acceptable salts of such compounds, useful as antiviral agents, are provided herein. Certain substituted arylthioureas disclosed herein are potent and/ or selective inhibitors of viral replication, particularly Hepatitis C virus replication. Pharmaceutical compositions containing one or more substituted arylthiourea compounds and one or more pharmaceutically acceptable carriers, excipients, or diluents are provided herein. Such pharmaceutical compositions may contain a substituted arylthiourea as the only active agent or may contain a combination of a substituted arylthiourea derivative and one or more other pharmaceutically active agents. Methods of treating Hepatitis C viral infections in mammals are also provided herein.
Patent EA-012702-B1 (EA)
Title: Substituted indazoles, compositions containing same, preparation and use
Inventor: HALLEY FRANCK
IPC: C07D405/12
Filed: 2005-06-01
Abstract: The invention concerns substituted indazoles of formula (I):compositions containing same, preparation and use thereof. The invention concerns in particular novel specific substituted indazoles exhibiting kinase inhibiting activity, having a therapeutic activity, particularly in oncology.
Patent EA-015753-B1 (EA)
Title: Method for degassing polymer powder
Inventor: DAMME ERIC
IPC: C08J3/00
Filed: 2007-03-06
Abstract: The present invention relates to a method for degassing polymer powder comprising flushing the polymer powder in a first chamber with a first flow of flushing gas, transferring the polymer powder into a second chamber and flushing the polymer powder with a second flow of flushing gas in said second chamber. The present invention also relates to a system suitable for carrying out this method.
Patent EA-017167-B1 (EA)
Title: Formulation for producing cellular, foamed-polymer product based on polyvinyl chloride, cellular, foamed-polymer product and a process for producing thereof (embodiments)
Inventor: LAURI LEONE
IPC: C08G18/62
Filed: 2007-06-05
Abstract: Formulation is proposed for producing cellular, foamed-polymer product based on polyvinyl chloride, comprising in mass % relative to total mass: a polyvinyl chloride homopolymer in a ratio 35/60 having a K-value of from 60 to 85 by DIN ES ISO 1628-2 and a pH value of the aqueous extract ranging of from 8 to 12 by DIN ES ISO 1060-2; at least one isocyanate in a ratio 20/50 selected from isomers and homologues of diphenylmethane-4,4'-diisocyanate and modified diphenylmethane-4,4'-diisocyanate s and mixtures thereof; at least one anhydride in a ratio 1/20 selected from the group of succinic anhydride, tetrahydrophthalic anhydride, hexahydrophthalic anhydride, methyl -tetrahydrophthalic anhydride, 4-methylhexahydrophthalic anhydride, cyclohexane-1,2-dicarboxylic anhydride, methylendomethylene tetrahydrophthalic anhydride, dodecenyl succinic anhydride, trimellitic anhydride and mixtures thereof; at least a surfactant in a ratio 0.08/0.8; at least a foaming agent in a ratio 0.5/7. There also is proposed a cellular, foamed-polymer product produced from said formulation and a process for producing said product (embodiments).
Patent EA-014144-B1 (EA)
Title: Method and apparatus for predicting the hydrocarbon production of a well location
Inventor: LEE DONALD
IPC: G01V11/00
Filed: 2007-02-08
Abstract: Methods and apparatus that use microseismic event data, stress data, seismic data, and rock properties to predict the hydrocarbon production success of a well location are disclosed. An example method generates a hydrocarbon production function based on information associated with at least a first well location, obtains information associated with a second well location, and calculates the hydrocarbon production function using the information associated with the second well location to predict the hydrocarbon production of the second well location.
Patent EA-016588-B1 (EA)
Title: Pyrazole analogs
Inventor: GRANETO MATTHEW J
IPC: A61K31/4155
Filed: 2007-11-14
Abstract: The invention relates to the compounds of formula (I), or a pharmaceutically acceptable salt and solvate thereof, wherein R1 is F or H and to processes for the preparation of, intermediates used in the preparation of, compositions containing the uses of, such compounds. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular allergic and respiratory diseases, disorders and conditions.
Patent EA-018702-B1 (EA)
Title: Biomechanical rotationally-correcting apparatus for lower extremity
Inventor: CHUGUNOV VITALIJ VIKTOROVICH
IPC: A61F5/00
Filed: 2009-12-15
Abstract: A biomechanical rotationally-correcting apparatus can be used for treating congenial hip dislocation, hip subluxation, spastic, spastic-torsion, paralytic hip subluxation in combination with pathologic configuration of thigh, tibia and foot both in adults and children and comprises an adjustable pelvic belt for holding around the user's pelvic region and adapted to centering the head of at least one thigh bone, at least one means of thigh bone in a given position capable of positioning turn in the horizontal plane, at least one means for turning knee joint adapted to correct its rotation axis in the frontal and horizontal planes, at least one means of tibia fixation in a given position adapted to turn the foot in the horizontal plane, at least one means of foot fixation relative to the ankle joint and correction volume of its movement, at least one means for foot positioning and a set of fixation elements each is a substantially cylindrical rod capable of linear positioning movement and/or rotation, and/or free linear movement used independently or in a various combination. The adjustable pelvic belt and at least one means of thigh bone fixation are fixed therebetween by a rod and form a first module. At least one means of thigh bone fixation in a given position, at least one means of knee joint turn and at least one means of tibia fixation in a given position are fixed therebetween by second and third rods and form a second module. At least one means of tibia fixation in a given position and at least one means of foot fixation are fixed therebetween by fourth rod and form a third module. The first, second and third modules can be used independently or in a given combination depending on pathologic configurations of user's lower extremities.
Patent EA-022200-B1 (EA)
Title: Building sheet material
Inventor: SCHROEER JOERN
IPC: E04B1/66
Filed: 2008-09-24
Abstract: The invention describes a sheet material (1) for the building sector, having at least one functional layer (2) and, if appropriate, at least one further layer, in particular a carrier layer and/or reinforcing layer (3), the functional layer (2) having a resistance to water-vapour diffusion (Svalue) which is dependent on the ambient humidity. According to the invention, it is provided that the functional layer (2) has at least one material (4) which can be obtained from a renewable raw material, in particular at least one polymer based on a renewable raw material.
Patent EA-017537-B1 (EA)
Title: Synthetic naphtha manufacturing method
Inventor: TANAKA YUICHI
IPC: C10G45/02
Filed: 2008-09-25
Abstract: The present invention relates to a method of manufacturing naphtha, wherein, in hydrogenation of a naphtha fraction which is fractionated from synthetic oil (FT synthetic oil) obtained by Fisher-Tropsch synthesis, the hydrogenised component is recycled and the recycled amount thereof is adjusted to reduce a olefin content in a hydro-refining apparatus whereby heat generation is suppressed and unstable operation of the hydro-refining apparatus can be stabilized. Furthermore, the present invention relates to a method of manufacturing naphtha, wherein a cut point for fractionating a naphtha fraction from FT synthetic oil is adjusted to reduce the amount of olefin in a hydro-refining apparatus whereby unstable operation of the hydro-refining apparatus can be stabilized.